bestseller

U.S. Telestroke Market - Industry Trends And Forecast To 2028

U.S. telestroke market is projected to register a CAGR of 18.6% in the forecast period of 2021 to 2028. The new market report contains data for historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 t

Region : 10133345548 | Price: 2900 | Report ID: 10133345548
U.S. telestroke market is projected to register a CAGR of 18.6% in the forecast period of 2021 to 2028. The new market report contains data for historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation

U.S. Telestroke Market, By Component (Software & Services and Hardware), Facilities Service (On-site and Remote), Care Settings (Mobile Stroke Units, intensive care units (ICUs), Emergency Departments (EDS), Medical Surgical Units and Others), Deployment Type (On-Premises and Cloud Based), Stroke Type (Ischemic, Haemorrhagic and Transient Ischemic Attack (TIA)), Application (Pre-Hospital and Hospital Care and Additional Applications), End user (Providers and Patients), Distribution Channel (Direct Tenders, Third Party Distribution and Retail Sales) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the U.S. telestroke market are:

Rising volume of patients suffering from stroke is driving the market growth.

Technological advancements in AI and its use in telestroke devices is supplementing the market growth

Market Players
Some of the major players operating in U.S. telestroke market are:

Abbott
GE Healthcare (a subsidiary of General Electric)
VeeMed
swyMe
TeleSpecialists
American Well
InTouch Technologies, Inc. (a subsidiary of Teladoc Health, Inc.)
iSchemaView, Inc.
The General Hospital Corporation
Brigham and Women's Hospital
Providence Health & Services
Medical University of South Carolina
Lakewood Health System
Nebraska Medicine
CentraCare
Mayo Foundation for Medical Education and Research (MFMER)
Rush Medical University Center
Penn Medicine
UCLA Health Medtronic



Short Description

U.S. Telestroke Market, By Component (Software & Services and Hardware), Facilities Service (On-site and Remote), Care Settings (Mobile Stroke Units, Intensive Care Units (ICUS), Emergency Departments (EDS), Medical Surgical Units and Others), Deployment Type (On-Premises and Cloud Based), Stroke Type (Ischemic, Haemorrhagic and Transient Ischemic Attack (TIA)), Application (Pre-Hospital and Hospital Care and Additional Applications), End user (Providers and Patients), Distribution Channel (Direct Tenders, Third Party Distribution and Retail Sales) Industry Trends and Forecast to 2028

Market Definition

Telestroke or stroke telemedicine refers to using technology by skilled personnel to treat stroke victims suffering from a stroke. They collaborate with local doctors to recommend them the treatment required for them. Patients and doctors communicate with each other over video conferencing, where a comprehensive stroke center acts as a primary medical center, and other remote locations act as originating sites. They are essentially used for treating strokes and are widely adopted by hospitals. Not only can they be deployed on-site, but also they can be deployed on the cloud as well in case of remote monitoring. Both software and hardware components are developed very precisely so that they can optimally serve the patients.
Market Segmentation
The U.S. telestroke market is segmented into component, facilities service, care settings, deployment type, stroke type, application, end user and distribution channel.
On the basis of component, U.S. telestroke market has been segmented into hardware and software & services.
On the basis of facilities service, U.S. telestroke market has been segmented into on-site and remote.
On the basis of care settings, U.S. telestroke market has been segmented into mobile stroke units, intensive care units (ICUs), emergency departments (EDs), medical surgical units, and others.
On the basis of deployment type, U.S. telestroke market has been segmented into on-premises and cloud-based.
On the basis of stroke type, U.S. telestroke market has been segmented into ischemic, hemorrhagic and transient ischemic attack (TIA).
On the basis of application, U.S. telestroke market has been segmented into pre-hospital and hospital care and additional applications.
On the basis of end user, U.S. telestroke market has been segmented into providers and patients.
On the basis of distribution channel, U.S. telestroke market has been segmented into direct tenders, third party distribution and retail sales.
Market Players
Some of the major players operating in U.S. telestroke market are:

Abbott
GE Healthcare (a subsidiary of General Electric)
VeeMed
swyMe
TeleSpecialists
American Well
InTouch Technologies, Inc. (a subsidiary of Teladoc Health, Inc.)
iSchemaView, Inc.
The General Hospital Corporation
Brigham and Women's Hospital
Providence Health & Services
Medical University of South Carolina
Lakewood Health System
Nebraska Medicine
CentraCare
Mayo Foundation for Medical Education and Research (MFMER)
Rush Medical University Center
Penn Medicine
UCLA Health Medtronic
TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF U.S. TELESTROKE MARKET 10
1.4 CURRENCY AND PRICING 12
1.5 LIMITATIONS 12
1.6 MARKETS COVERED 13
2 MARKET SEGMENTATION 16
2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 DBMR TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 DBMR MARKET POSITION GRID 23
2.7 VENDOR SHARE ANALYSIS 24
2.8 MULTIVARIATE MODELING 25
2.9 COMPONENT TIMELINE CURVE 25
2.10 MARKET APPLICATION COVERAGE GRID 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 31
5 MARKET OVERVIEW 32
5.1 DRIVERS 34
5.1.1 RISING VOLUME OF PATIENTS SUFFERING FROM STROKES 34
5.1.2 GROWING NEED TO REDUCE THE RISK OF NEURAL STROKES 34
5.1.3 INCREASING APPROVALS OF TELESTROKE DEVICES BY FDA 34
5.1.4 COST EFFECTIVENESS OF TELESTROKE SERVICES 35
5.2 RESTRAINTS 36
5.2.1 RISING HEALTHCARE FRAUD 36
5.2.2 ISSUES REGARDING INSUFFICIENT REIMBURSEMENT 36
5.3 OPPORTUNITIES 37
5.3.1 GROWING EXPENDITURE IN R&D 37
5.3.2 TECHNOLOGICAL ADVANCEMENTS IN AI AND ITS USE IN TELESTROKE 37
5.4 CHALLENGES 38
5.4.1 LICENSURE AND CREDENTIALING CONSTRAINTS 38
5.4.2 INFRASTRUCTURE AND TECHNOLOGICAL CHALLENGES 38
5.4.3 PHYSICIAN BUY-IN AND TELESTROKE STAFF TRAINING 39
6 COVID-19 IMPACT ON THE U.S. TELESTROKE MARKET IN SEMICONDUCTORS AND ELECTRONICS INDUSTRY 40
6.1 PRICE IMPACT 40
6.2 IMPACT ON DEMAND 40
6.3 IMPACT ON SUPPLY CHAIN 40
6.4 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE 40
6.5 CONCLUSION 40
7 U.S. TELESTROKE, BY COMPONENT 41
7.1 OVERVIEW 42
7.2 HARDWARE 43
7.3 SOFTWARE & SERVICES 43
8 U.S. TELESTROKE, BY FACILITIES SERVICES 44
8.1 OVERVIEW 45
8.2 ON-SITE 46
8.2.1 ON-SITE 46
8.2.1.1 AUDIOVISUAL COMMUNICATION SYSTEM 46
8.2.1.2 NEUROLOGIST AND ATTENDING NURSE 46
8.2.1.3 ELECTRONIC HEALTHCARE RECORD (EHR) 46
8.2.1.4 PRACTICE MANAGEMENT SYSTEM (PMS) 46
8.2.1.5 OTHERS 46
8.2.2 AUDIO-VISUAL COMMUNICATION 47
8.2.2.1 DESKTOP COMPUTER 47
8.2.2.2 LAPTOP 47
8.2.2.3 PHONE 47
8.2.2.4 TABLET 47
8.2.2.5 CT / BRAIN IMAGE TRANSFER CAPABILITY (DICOM SERVER) 47
8.2.2.6 OTHERS 47
8.3 REMOTE 48
8.3.1 REMOTE 48
8.3.1.1 AUDIOVISUAL COMMUNICATION SYSTEM 48
8.3.1.2 WELL QUALIFIED MEDICAL PROFESSIONAL 48
8.3.1.3 OTHERS 48
8.3.2 AUDIO-VISUAL COMMUNICATION 49
8.3.2.1 PHONE 49
8.3.2.2 LAPTOP 49
8.3.2.3 TABLET 49
8.3.2.4 DESKTOP COMPUTER 49
8.3.2.5 OTHERS 49
9 U.S. TELESTROKE, BY CARE SETTINGS 50
9.1 OVERVIEW 51
9.2 MOBILE STROKE UNITS 52
9.2.1 MOBILE STROKE UNITS 52
9.2.1.1 ADVANCED TELEMEDICINE DEVICES 52
9.2.1.2 CT SCANNER 52
9.2.1.3 OTHERS 52
9.3 INTENSIVE CARE UNITS (ICUS) 53
9.4 EMERGENCY DEPARTMENTS (EDS) 53
9.5 MEDICAL SURGICAL UNITS 53
9.6 OTHERS 53
10 U.S. TELESTROKE, BY DEPLOYMENT TYPE 54
10.1 OVERVIEW 55
10.2 ON-PREMISES 56
10.3 CLOUD-BASED 56
11 U.S. TELESTROKE, BY STROKE TYPE 57
11.1 OVERVIEW 58
11.2 ISCHEMIC 59
11.2.1 ISCHEMIC 59
11.2.1.1 THROMBOTIC 59
11.2.1.2 EMBOLIC 59
11.3 HEMORRHAGIC 59
11.3.1 HEMORRHAGIC 60
11.3.1.1 INTRACEREBRAL HEMORRHAGE 60
11.3.1.2 SUBARACHNOID HEMORRHAGE 60
11.4 TRANSIENT ISCHEMIC ATTACK (TIA) 60
12 U.S. TELESTROKE, BY APPLICATION 61
12.1 OVERVIEW 62
12.2 PRE-HOSPITAL AND HOSPITAL CARE 63
12.3 ADDITIONAL APPLICATIONS 63
12.3.1 ADDITIONAL APPLICATIONS 63
12.3.1.1 WELLNESS & REMOTE MONITORING 63
12.3.1.2 DISEASE PREVENTION 63
12.3.1.3 REHABILITATIVE 63
12.3.1.4 OTHERS 63
13 U.S. TELESTROKE, BY END USER 64
13.1 OVERVIEW 65
13.2 PROVIDERS 66
13.2.1 PROVIDERS 66
13.2.1.1 TELEHOSPITALS/TELECLINICS 66
13.2.1.2 TELEHOME 66
13.2.1.3 OTHERS 66
13.3 PATIENTS 66
14 U.S. TELESTROKE, BY DISTRIBUTION CHANNEL 67
14.1 OVERVIEW 68
14.2 DIRECT TENDERS 69
14.3 THIRD PARTY DISTRIBUTION 69
14.4 RETAIL SALES 69
15 U.S. TELESTROKE MARKET: COMPANY LANDSCAPE 70
15.1 COMPANY SHARE ANALYSIS: U.S. 70
16 COMPANY PROFILE 71
16.1 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC) 71
16.1.1 COMPANY SNAPSHOT 71
16.1.2 REVENUE ANALYSIS 71
16.1.3 PRODUCT PORTFOLIO 72
16.1.4 1.1.4 RECENT DEVELOPMENTS 72
16.2 MEDTRONIC 74
16.2.1 COMPANY SNAPSHOT 74
16.2.2 REVENUE ANALYSIS 74
16.2.3 PRODUCT PORTFOLIO 75
16.2.4 RECENT DEVELOPMENT 75
16.3 ABBOTT 76
16.3.1 COMPANY SNAPSHOT 76
16.3.2 REVENUE ANALYSIS 76
16.3.3 PRODUCT PORTFOLIO 77
16.3.4 RECENT DEVELOPMENT 77
16.4 AMERICAN WELL 78
16.4.1 COMPANY SNAPSHOT 78
16.4.2 REVENUE ANALYSIS 78
16.4.3 SERVICE PORTFOLIO 79
16.4.4 RECENT DEVELOPMENTS 79
16.5 INTOUCH TECHNOLOGIES INC. (A SUBSIDIARY OF TELADOC HEALTH, INC.) 80
16.5.1 COMPANY SNAPSHOT 80
16.5.2 REVENUE ANALYSIS 80
16.5.3 SOLUTION PORTFOLIO 81
16.5.4 RECENT DEVELOPMENT 81
16.6 ISCHEMAVIEW, INC. 82
16.6.1 COMPANY SNAPSHOT 82
16.6.2 PRODUCT PORTFOLIO 82
16.6.3 RECENT DEVELOPMENT 83
16.7 SWYME 84
16.7.1 COMPANY SNAPSHOT 84
16.7.2 PRODUCT PORTFOLIO 84
16.7.3 RECENT DEVELOPMENT 84
16.8 TELESPECIALISTS 85
16.8.1 COMPANY SNAPSHOT 85
16.8.2 SERVICE PORTFOLIO 85
16.8.3 RECENT DEVELOPMENTS 85
16.9 VEEMED 87
16.9.1 COMPANY SNAPSHOT 87
16.9.2 SERVICE PORTFOLIO 87
16.9.3 RECENT DEVELOPMENTS 88
17 QUESTIONNAIRE 89
18 RELATED REPORTS 93

 

Research Methodology

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.